AZ-1355
CAS: 75451-07-9
Ref. 3D-ADA45107
| 1mg | 1,056.00 € | ||
| 5mg | 2,984.00 € | ||
| 10mg | 4,774.00 € | ||
| 25mg | 8,951.00 € | ||
| 50mg | 14,321.00 € |
Product Information
- Az-1355
- 10,11-Dihydro-4-methoxydibenz[b,f][1,4]oxazepine-8-carboxylic acid ethyl ester
- Ethyl 4-Methoxy-10,11-Dihydrodibenzo[B,F][1,4]Oxazepine-8-Carboxylate
AZ-1355 is a novel, orally bioavailable, small molecule inhibitor of collagen-specific proteinase (MMP-1) that has been shown to be effective in preventing the development of cerebral amyloidosis in hamsters. AZ-1355 is orally bioavailable and penetrates the blood brain barrier, thus reducing the amount of MMP-1 that can enter the brain. This drug has also been shown to reduce cardiac collagen deposition and improve endothelial function. AZ-1355 has not been tested on humans or animals for its potential toxicity, but it does have a toxic profile in vitro. This drug has also been shown to have damaging effects on platelets and cause death in cultured cells.
Chemical properties
Technical inquiry about: 3D-ADA45107 AZ-1355
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
